Page 574 - Read Online
P. 574

Page 10 of 19                   Cordover et al. J Cancer Metastasis Treat 2020;6:45  I  http://dx.doi.org/10.20517/2394-4722.2020.101


































               Figure 3. PI3K/AKT/mTOR signaling cascade: The PI3K/AKT/mTOR pathway is activated through RTK signaling, and hyperactivation
               of this pathway is implicated in several cancers. The main effectors of this pathway, mTORC1 and mTORC2, are major regulators of
               translation, cell metabolism, and cell proliferation. RTK: receptor tyrosine kinase; PI3K: phosphoinositide 3-kinase; AKT: protein kinase B;
               mTOR: mammalian target of rapamycin


               and autophosphorylation of tyrosine residues of RTKs recruit PI3K to the membrane and activate its
               catalytic subunit. PI3K activation leads to the phosphorylation of PIP2 to produce secondary messenger
               phosphatidylinositol (3, 4, 5)- trisphosphate (PIP3). PIP3 amplifies the initial signal from PI3K and
               subsequently recruits 3’-phosphoinositide-dependent kinase-1 (PDK1) and protein kinase B/Akt to the
               membrane. PDK1 is responsible for the activation of Akt, and Akt in turn regulates several downstream
                                                                                       [64]
               effectors. Notably, Akt activates the Forkhead Box O proteins and the mTOR pathway .
               The mTOR pathway is a major regulator of translation and consists of two complexes, mTORC1 and
               mTORC2. AKT can both directly and indirectly activate the mTOR pathway. AKT is shown to activate the
               mTORC1 complex through the phosphorylation and subsequent inactivation of two negative regulators of
               the mTOR pathway - tuberous sclerosis complex 2 and PRAS40 (proline-rich Akt substrate of 40kDa). In
               mTORC1, mTOR associates with Raptor, which regulates mTOR activity and recruits mTORC1 substrates.
               mTORC1 regulates ribosomal proteins S6K and 4E-BP1, which have roles in regulating protein synthesis
                              [65]
               and metabolism  [Figure 3]. The phosphorylation and activation of S6K by mTORC1 leads to the
               phosphorylation of S6, which advances mRNA translation and further promotes the synthesis of rRNAs,
               tRNAs, and transcription factors. On the other hand, mTORC1 inactivates 4E-BP1 which plays a role in
               the inhibition of translation. Hence, when 4E-BP1 is phosphorylated by mTORC1, translation initiation is
                        [66]
               promoted . Unlike mTORC1, less is known about the activation and regulation of mTORC2. However,
               evidence shows that mTORC2 is activated by PIP3 and growth signals that can promote cell proliferation
               and survival [Figure 3]. Similar to the role that Raptor has in mTORC1 regulation, Rictor associates with
               mTORC2 and is important in stabilizing and monitoring mTORC2 activity. Additionally, mTORC2 is
               shown to regulate small GTPases and members of the AGC kinase family, which includes AKT, PKC, and
               SGK1 (protein kinase C) [64,67] . As such, the dysregulation of both mTORC1 and mTORC2 have been shown
               to exert oncogenic effects.
   569   570   571   572   573   574   575   576   577   578   579